Phillip Sharp discusses RNAi, Nobel Prizes and entrepreneurial science

Drug Discovery Today

Volumn 10, Issue 1, 2005, Pages 7-10

  Watson, Christopher ^b   Sharp, Phillip A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NONE

Author keywords

Apolipoprotein B; Biochemistry; Drug Discovery; Erythropoietin; Hepatitis B; Immunology; Pharmaceutical Science; RNA splicing; RNAi

Indexed keywords

SMALL INTERFERING RNA;

ACHIEVEMENT; BIOTECHNOLOGY; CAREER; CHEMISTRY; DRUG INDUSTRY; DRUG RESEARCH; DRUG TARGETING; FINANCIAL MANAGEMENT; GENETIC ANALYSIS; MATHEMATICS; MEDICAL SCHOOL; MOLECULAR BIOLOGY; NOTE; POSTGRADUATE EDUCATION; RNA INTERFERENCE; RNA SPLICING; SCIENCE;

EID: 12844261680     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03329-X     Document Type: Short Survey

References (1)

1. Soutschek J., et al. Therapeutic silencing of an endogenous gene by systematic administration of modified siRNAs. Nature. 432:2004;173-178